Page 1 of 6 · 101 results
|
Symbol
|
Sector
|
Firm
|
Action
|
Grade
|
Target
|
Mkt Cap ▼
|
Base
|
Gap%
|
D1%
|
D2%
|
D3%
|
D4%
|
D5%
|
|
NVDA
|
Technology |
Susquehanna |
Maintains
|
Positive
→
Positive
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Mizuho |
Maintains
|
Buy
→
Buy
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Jefferies |
Maintains
|
Buy
→
Buy
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Wells Fargo |
Maintains
|
Overweight
→
Overweight
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Oppenheimer |
Maintains
|
Outperform
→
Outperform
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Needham |
Maintains
|
Buy
→
Buy
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Credit Suisse |
Maintains
|
Outperform
→
Outperform
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Rosenblatt |
Maintains
|
Buy
→
Buy
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
NVDA
|
Technology |
Citigroup |
Maintains
|
Buy
→
Buy
|
—
|
$5.4T
|
$12.14
|
-1.3%
|
+0.0%
|
+4.4%
|
+0.3%
|
+0.2%
|
+0.2%
|
|
ABBV
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$376.6B
|
$96.10
|
-0.6%
|
-0.9%
|
-0.4%
|
-0.4%
|
-0.5%
|
+0.3%
|
|
BABA
|
Consumer Cyclical |
Truist |
Maintains
|
Buy
→
Buy
|
—
|
$324.7B
|
$260.59
|
-1.4%
|
-1.0%
|
+3.0%
|
+3.8%
|
+3.6%
|
+2.1%
|
|
BABA
|
Consumer Cyclical |
CLSA |
Maintains
|
Buy
→
Buy
|
—
|
$324.7B
|
$260.59
|
-1.4%
|
-1.0%
|
+3.0%
|
+3.8%
|
+3.6%
|
+2.1%
|
|
ADI
|
Technology |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$197.7B
|
$118.15
|
-0.4%
|
-0.6%
|
-1.2%
|
+1.0%
|
+2.3%
|
+0.5%
|
|
PANW
|
Technology |
Deutsche Bank |
Maintains
|
Buy
→
Buy
|
—
|
$170.3B
|
$44.91
|
-0.4%
|
+1.1%
|
-1.2%
|
-0.8%
|
-2.3%
|
+0.9%
|
|
TJX
|
Consumer Cyclical |
Barclays |
Maintains
|
Overweight
→
Overweight
|
—
|
$169.5B
|
$54.36
|
-1.8%
|
-5.0%
|
+0.1%
|
+3.3%
|
-0.5%
|
+0.2%
|
|
TJX
|
Consumer Cyclical |
Credit Suisse |
Maintains
|
Outperform
→
Outperform
|
—
|
$169.5B
|
$54.36
|
-1.8%
|
-5.0%
|
+0.1%
|
+3.3%
|
-0.5%
|
+0.2%
|
Page 1 of 6 · 101 results